Methyl 4-Methyl-1H-pyrrole-2-carboxylate, 97.0%, 1g

N-methyl-1-(5-phenyl-1H-pyrazol-3-yl)methanamine oxalate, 95.0%, 1g

(4-Bromo-benzothiazol-2-yl)-carbamic acid tert-butyl ester, 95%, 500mg

4-(Vinylsulfonamido)benzoic acid, 98%, 250mg

4-Methyltetrahydro-2H-pyran-4-ol, 95.0%, 10g

1-Ethyl-4-(piperidin-4-yl)piperazine trihydrochloride, 98%, 25g

1-(2,6-Dimethoxynaphthalen-1-yl)ethan-1-one, 98%, 1g

H-Glu(OMe)-OMe.HCl, 98%, 25g

(E)-2-(2-Nitroethenyl)thiophene, 95.0%, 25g

2,6-Dibromo-4-methylphenol, 95.0%, 25g

2-(N-cyclopropylcarbamoyl)cyclohexanecarboxylic acid, 97%, 10g

6-Fluoropyridin-2-ylboronic acid, 95.0%, 1g

Cubetas de electroporación 450 µl 50 uds.